Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa
Abstract Factor XIa (FXIa) is a serine protease that catalyzes the activation of Factor IX (FIX) in the blood coagulation cascade. FXIa and its precursor FXI are emergent therapeutic targets for the development of safer anticoagulant agents. Here, we sought a novel DNA-based agent to inhibit FXIa. T...
Guardado en:
Autores principales: | David A. Donkor, Varsha Bhakta, Louise J. Eltringham-Smith, Alan R. Stafford, Jeffrey I. Weitz, William P. Sheffield |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4219d136fc514ca4a4f9663c24f5819f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis
por: Varsha Bhakta, et al.
Publicado: (2021) -
Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX
por: Guodong Wang, et al.
Publicado: (2017) -
Cuando estuve en el pueblo de Xia
por: Ding Ling, et al.
Publicado: (1986) -
Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
por: Andrea M. Costello, et al.
Publicado: (2021) -
DNA aptamers against the Lup an 1 food allergen.
por: Pedro Nadal, et al.
Publicado: (2012)